Who Owns Protara Therapeutics Stock?
NASDAQ: TARAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 74.93%
- Held by insiders
- 2.21%
- Institutional holders
- 151
- Institutions 74.9%
- Insiders 2.2%
- Public and other 22.9%
Who owns Protara Therapeutics stock?
Institutional investors own about 74.9% of Protara Therapeutics's shares, spread across 151 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.21% of TARA.
The largest institutional holders are Blackrock Inc. (6.02%), Millennium Management Llc (5.04%) and Velan Capital Investment Management LP (4.62%). Together, the top 10 institutions control 39.6% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their TARA positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TARA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 3.71M | 6.02% | +1.2% |
| Millennium Management Llc | 3.10M | 5.04% | +9.5% |
| Velan Capital Investment Management LP | 2.84M | 4.62% | 0.0% |
| Rosalind Advisors, Inc. | 2.40M | 3.90% | +100.0% |
| Blackstone Inc | 2.37M | 3.84% | +4.5% |
| Vanguard Capital Management LLC | 2.30M | 3.74% | 0.0% |
| Citadel Advisors Llc | 2.09M | 3.39% | +69.4% |
| Sio Capital Management, LLC | 1.99M | 3.23% | +3.6% |
| Baker Bros. Advisors, LP | 1.84M | 2.99% | +89.8% |
| Acorn Capital Advisors, LLC | 1.75M | 2.85% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TARA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.66M | 2.69% |
| iShares Trust-iShares Russell 2000 ETF | 1.37M | 2.23% |
| Columbia Funds Series Trust I-Columbia Small Cap Value Discovery Fund | 758.07K | 1.23% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 586.97K | 0.95% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 569.27K | 0.92% |
| iShares Trust-iShares Russell 2000 Value ETF | 516.84K | 0.84% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 299.20K | 0.49% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 253.48K | 0.41% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Portfolio | 182.47K | 0.30% |
| iShares Trust-iShares Micro-Cap ETF | 168.29K | 0.27% |
Frequently asked questions
Who is the largest shareholder of Protara Therapeutics?
Blackrock Inc. is the largest institutional shareholder of TARA, owning 6.02% of shares outstanding (3.71M shares) as of its latest 13F filing.
What percentage of Protara Therapeutics is owned by institutions?
Institutions own about 74.9% of TARA shares and 76.6% of the public float.
How much of Protara Therapeutics do insiders own?
Insiders, such as officers and directors, own about 2.21% of TARA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.